Assessing exposure levels involves air sampling, surface sampling, and biomonitoring. Air sampling can detect airborne nanoparticles, while surface sampling identifies contamination on work surfaces and equipment. Biomonitoring measures the concentration of nanoparticles in biological samples like blood or urine, providing insights into the internal dose received by individuals.
